Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)

Prenetics Global Limited announced a $1 billion growth financing deal with General Catalyst's Customer Value Fund to accelerate IM8's marketing spend. The company raised its full-year 2026 revenue guidance to $210-220 million (from $190-210 million) and projects $300 million annualized run-rate by year-end 2026 and $400+ million in full-year 2027 revenue. IM8, co-founded by David Beckham, has become the fastest-growing premium supplement brand ever, delivering 200,000 servings daily across 43 countries with strong unit economics ($1.44 gross profit return per $1 acquisition spend).